BioFeedbackKnow your patients’ specialty infusion outcomes.
BioFeedback, an outcomes-reporting program from Diplomat Specialty Infusion Group, enables the right interventions at the right time. As pharmacy spend shifts toward specialty, it’s more important than ever to understand how complex therapies are working in the real world. BioFeedback keeps every member of the healthcare team informed.
Developed in consultation with leading medical experts, BioFeedback includes:
- Disease- and therapy-specific reports
- Routine, trended reports
- Post-infusion reports for IVIG
BioFeedback offers reports for these conditions:
- Alpha-1 antitrypsin deficiency
- Autoimmune neuropathies (immune globulin)
- Hereditary angioedema
- Primary immunodeficiencies (immune globulin)
To request more information, please complete the form.